Filtered By:
Source: Neurology
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 235 results found since Jan 2013.
Eligibility for revascularization in acute stroke: a 12 year single center statistics (P2.288)
Conclusions: Of patients arriving within 6 hours at a comprehensive stroke center, 10.5[percnt] are EVT-eligible according to AHA/ASA criteria, 17.7[percnt] with criteria resembling randomized controlled trials, and double for IV thrombolysis (36.2[percnt]). These figures may be useful for planning resource needs of stroke care on a regional level. Disclosure: Dr. Vanacker has nothing to disclose. Dr. Lambrou has nothing to disclose. Dr. Eskandari has nothing to disclose. Dr. Mosimann has nothing to disclose. Dr. Michel has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Vanacker, P., Lambrou, D., Eskandari, A., Mosimann, P., Michel, P. Tags: Acute Endovascular Therapy: Other Considerations Source Type: research
Comparison of Ventricular Assist Device (VAD)-Related Stroke to the General Stroke Population: Associations with In-Hospital Mortality (P1.223)
Conclusions: Ischemic stroke in patients with VAD is associated with high in-hospital mortality. Although both older patients and women comprised a smaller percentage of VADWS than in the general stroke population, there was no age or sex association with mortality. While pre-existing CAD was more prevalent in VADWS, these patients had lower in-hospital mortality, possibly suggesting an additional unidentified subset with high mortality. Further study is needed to explore the associations between age, sex, and CAD in patients with VAD and ischemic stroke.Disclosure: Dr. Peters has nothing to disclose. Dr. Singh has nothing...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Peters, S., Singh, T., Tirschwell, D. Tags: Cardiac Mechanisms and Complications of Stroke Source Type: research
Association Between Anthropometric Measurements and Stroke in Patients with Low CHADS2 Score (P1.226)
Conclusion: In contrast to the available literature, we found that patients with low risk CHADS2 score with subsequent acute stroke were taller with statistical significance than those with high CHADS2 score. The implication of this finding is that such variations in anthropometric measurements might predispose patients with atrial fibrillation to higher risk of stroke regardless of their CHADS2 score. Accordingly, stroke risk stratification models should include these measurements in contemporary practice.Disclosure: Dr. Hassan has nothing to disclose. Dr. Villines has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Hassan, A., Villines, D. Tags: Cardiac Mechanisms and Complications of Stroke Source Type: research
Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation among Cardiologists, Internists, and Vascular Neurologists (P1.227)
Conclusions: Medical specialties differ in their reasons for selecting NOACs over warfarin and in their use of aspirin with warfarin. Educational interventions may prevent misinterpretations of clinical trial results, particularly with regards to comparative efficacy in the prevention of ischemic stroke and intracerebral hemorrhage. Disclosure: Dr. Leung has nothing to disclose. Dr. Mcallister has nothing to disclose. Dr. Selim has nothing to disclose. Dr. Fisher has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Leung, L., Mcallister, M., Selim, M., Fisher, M. Tags: Cardiac Mechanisms and Complications of Stroke Source Type: research
Mismanagement of Atrial Fibrillation (AF) as a Modifiable Risk Factor (MRF) for Ischemic Stroke (iStroke) (P1.228)
Conclusions: The management of AF improves after the first ischemic event. Anticoagulation in AFis related to a lower incidence of early disability in the setting of iStroke.Disclosure: Dr. Giannaula has received personal compensation for activities with Boehringer Ingelheim. Dr. Sanz has nothing to disclose. Dr. Huerta has nothing to disclose. Dr. Pagano Ajolfi has nothing to disclose. Dr. Malmierca has nothing to disclose. Dr. Alfonso has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Giannaula, R., Sanz, P., Huerta, M., Pagano Ajolfi, S., Malmierca, A., Alfonso, A. Tags: Cardiac Mechanisms and Complications of Stroke Source Type: research
Atrial Fibrillations Effect on the Rate of Ischemic Stroke, Death and Disability in Subarachnoid Hemorrhage (P1.256)
Conclusion: There are significantly decreased rates of favorable outcomes in subarachnoid hemorrhage patients with atrial fibrillation. Further studies are warranted to better understand the associated factors.Disclosure: Dr. Hassan has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Chaudhry has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Sanchez has nothing to disclose. Dr. Tekle has nothing to disclose. Dr. Qureshi has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Hassan, A., Afzal, M. R., Chaudhry, S., Sanchez, C., Sanchez, C., Tekle, W., Qureshi, A., Riaz, A. Tags: Aneurysms and Subarachnoid Hemorrhage Source Type: research
Alcoholism and In-Hospital Mortality among Hemorrhagic Stroke Patients in Puerto Rico (P1.263)
Conclusions: The adjusted OR of 3.18 suggests a positive association and in-patient hemorrhagic stroke mortality. However the small sample size and low power limit the ability to delineate a clear statistical association, thereby warranting further study into this subject matter as alcoholism is a modifiable risk factor and early interventions may lower hemorrhagic stroke mortality in this population.Disclosure: Dr. Smirnoff has nothing to disclose. Dr. Moses has nothing to disclose. Dr. Zevallos has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Smirnoff, L., Moses, A., Zevallos, J. C. Tags: Cerebrovascular Disease: Health Disparities Source Type: research
Rheumatic Valve Disease and Stroke. A Public Health Problem in Countries in Way of Develop (P1.288)
Conclusions: In our population RVD with or without AF is the main cause of cerebral ischemia, just preceded by thrombosis of large arteries, affecting young and productive people, which severely impacts the economy of families and country that walking towards development. Mexico along with other emerging countries needs to implement public health programs in the early diagnosis and treatment of this health problem.Disclosure: Dr. Mendez-Dominguez has nothing to disclose. Dr. Arias-Fernandez has nothing to disclose. Dr. Aguirre-Delfin has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Mendez-Dominguez, A., Arias-Fernandez, J., Aguirre-Delfin, M. Tags: Global Health: Infectious Disease, Capacity Building, and Other Source Type: research
From 'Sweet Clover Disease' to NOACs: A Historical Perspective on Oral Anticoagulation for Prevention of Cardioembolic Stroke (P2.397)
CONCLUSIONS: Warfarin, born from ‘sweet clover disease’ and humble beginnings as rodenticide, has been the cornerstone of cardioembolic stroke prevention. Its shortcomings inspired the development of a new generation of oral anticoagulants.Disclosure: Dr. Chiota-McCollum has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Chiota-McCollum, N. Tags: History of Neurology Source Type: research
An Uncommon Cause for Multiple Cerebral Ischemic Infarcts (P4.344)
Conclusions: Cerebral infarcts due to CM in immunocompetent patients are unusual. However, cryptococcal infection should be considered in atypical stroke manifestations, since early diagnosis and prompt treatment can improve outcome.Disclosure: Dr. Khattak has nothing to disclose. Dr. Desai has nothing to disclose. Dr. Desai has nothing to disclose. Dr. Wise has nothing to disclose. Dr. Moore has nothing to disclose. Dr. Shah has nothing to disclose. Dr. Wilder has nothing to disclose. Dr. Remmel has nothing to disclose. Dr. Liu has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Khattak, J., Desai, M., Desai, D., Wise, E., Moore, K., Shah, J., Wilder, M., Remmel, K., Liu, W. Tags: Cerebrovascular Case Reports Source Type: research
Factors Affecting Blood Pressure Control Post-Stroke (P5.215)
CONCLUSIONS: Both SBP and DBP increased significantly from the time of discharge to follow-up in the stroke clinic, but patients with a documented PCP were able to achieve better control of their BP.Disclosure: Dr. McDaniel has nothing to disclose. Dr. Conners has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Song has nothing to disclose. Dr. Cutting has nothing to disclose. Dr. Cherian has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: McDaniel, J., Conners, J., Lee, V., Song, S., Cutting, S., Cherian, L. Tags: Cerebrovascular Disease: Genetics and Risk Factor Variation Source Type: research
Risk Factors for Blood-Brain Barrier Disruption in Patients with Chronic Cerebrovascular Disease Presenting with Acute Stroke (P2.245)
Conclusions: These findings suggest that cWMD caused by chronic hypertension may have a different underlying pathophysiology than cWMD that is associated with aging.Disclosure: Dr. Gupta has nothing to disclose. Dr. Luby has nothing to disclose. Dr. Nadareishvili has nothing to disclose. Dr. Benson has nothing to disclose. Dr. Hsia has nothing to disclose. Dr. Lynch has nothing to disclose. Dr. Leigh has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Gupta, N., Luby, M., Nadareishvili, Z., Benson, R., Hsia, A., Lynch, J., Leigh, R. Tags: Aging and Dementia: Other Source Type: research
Incidence of Atrial Fibrillation within One Year of Cryptogenic Stroke among a Large, Real-World Population with Insertable Cardiac Monitors (I2.005)
Conclusions: AF episodes were detected via continuous monitoring with ICMs in almost 1 of every 6 CS patients within 1 year of follow-up. Most patients with AF had at least one episode lasting >1 hour and the first AF episode occurred beyond the range of conventional external ambulatory monitors in the vast majority of patients. Therefore ICMs should be strongly considered in the evaluation of CS patients.Disclosure: Dr. Rogers has received research support from Medtronic. Dr. Nichols holds stock and/or stock options in Medtronic. Dr. Richards has received personal compensation for activities with Janssen. Dr. Ferreira ...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Rogers, J., Nichols, A., Richards, M., Ferreira, S., Sarkar, S., Koehler, J., Warman, E., Ziegler, P. Tags: Stroke in the Elderly and Young: Challenges for the Next Decade Data Blitz Presentations Source Type: research
Rate of Endovascular Therapy in Octogenarian/Nonagenarian Acute Ischemic Stroke Patients Compared to Younger Patients (I2.007)
Conclusions: Frequency of EVT and IV-TPA use in AIS patients 蠅80years are increasing but rates remain significantly lower compared with younger patients. Disparity in EVT use in octogenarian/nonagenarian also exists by race and hospital factors. Targeted efforts are needed to lessen this disparity.Disclosure: Dr. Otite has nothing to disclose. Dr. Khandelwal has nothing to disclose. Dr. Tipirneni has nothing to disclose. Dr. Fellman has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Yavagal has received personal compensation for activities with Covidien/evV3 as a consultant and Steering Committee Member...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Otite, F., Khandelwal, P., Tipirneni, A., Fellman, M., Malik, A., Yavagal, D., Chaturvedi, S. Tags: Stroke in the Elderly and Young: Challenges for the Next Decade Data Blitz Presentations Source Type: research
Exploring Protein Quantitation Methods to Detect Useful Plasma Biomarkers for Distinguishing Ischemic Stroke from Mimic (I2.013)
Conclusions: These results provide proof of concept that proteomic signals can be useful in ACVS diagnosis in more severe cases.The analyses have shaped our prospective verification (completed, n=560) and validation studies (ongoing, n=1200) of the use of proteomics in the diagnosis of mimic vs. mild-ACVS in early Emergency Department triage.Disclosure: Dr. Penn has received personal compensation for activities with Pfizer, Boehringer Ingelheim Pharmaceuticals, Inc., and Bayer as a speaker. Dr. Balshaw has nothing to disclose. Dr. Lesperance has nothing to disclose. Dr. Saly has nothing to disclose. Dr. Jackson has nothing...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Penn, A., Balshaw, R., Lesperance, M., Saly, V., Jackson, A., Smith, D., Votova, K., Lu, L., Morrison, J., Coutts, S., Borchers, C. Tags: Stroke in the Elderly and Young: Challenges for the Next Decade Poster Presentations Source Type: research
